Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-07-30
Hooley Joseph L Files Idexx Laboratories (IDXX) Form 4 - July 30, 2026
Hooley Joseph L bought 49 IDXX shares worth $27.4K in this Form 4 filing, reported to the SEC on 2026-07-30.
- Insider
- Hooley Joseph L
- Issuer
- Idexx Laboratories, Inc. IDXX · NASDAQ
- Filed
- Period
- 2026-07-30
- Accession
- 0000874716-26-000117
- Source
- Official filing on sec.gov ↗
Transactions (1)
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| Hooley Joseph L | 2026-07-30 | Buy | 49 | $558.80 | $27.4K | Direct |
| Net change | +49 | +$27.4K | ||||
About Idexx Laboratories, Inc.
Idexx Laboratories, Inc. is a prominent player in the health technology industry, specializing in veterinary diagnostics, software, and water microbiology testing. The company develops and markets products and services that enhance animal health and well-being, offering a wide range of diagnostic tests for companion animals, livestock, and poultry. It is notably recognized for providing innovative diagnostic services including in-house analyzers and rapid assays, which facilitate quick and accurate diagnostic results for veterinarians. Besides its veterinary focus, Idexx Laboratories also provides water testing solutions aimed at ensuring the safety and quality of water supplies by identifying microbial contaminants. The firm’s advanced diagnostic technologies significantly impact the animal health sector by delivering efficient, reliable diagnostics that enable proactive animal care. Idexx stands out as a key player in enhancing laboratory efficiency through its cloud-based practice management software, improving day-to-day operations for veterinary practices worldwide. Headquartered in Westbrook, Maine, Idexx Laboratories' mission and products underscore its vital role in advancing global animal health and environmental testing solutions, making it a significant entity in the health technology market.
Track IDXX insider activity
Get alerted when Idexx Laboratories, Inc. executives buy or sell their shares.